DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States | Secondary Sources | Westlaw

DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States, Secondary Sources
Skip Page Header

DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States

20 No. 16 WJBLL 20Westlaw Journal Bank & Lender Liability (Approx. 4 pages)

DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES Purdue Pharma v. United States

20 No. 16 WJBLL 20Westlaw Journal Bank & Lender Liability (Approx. 4 pages)

20 No. 16 Westlaw Journal Bank & Lender Liability 20
Westlaw Journal Bank & Lender Liability
*1 December 29, 2014
Health Care Fraud
Copyright © 2014 Thomson Reuters .

DRUG COMPANY ASKS SUPREME COURT TO HOLD OFF ON REVIEW OF FCA ISSUES

Purdue Pharma v. United States

Briefs and Other Related Documents
A pharmaceutical company has asked the U.S. Supreme Court to hold its certiorari petition seeking review of an appeals court's decision on two False Claims Act issues until the high court rules in a pending, unrelated case.
Purdue Pharma LP et al. v....
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.